Healthcare provider profile · identity verified

Ronald L Johnson, MD

Family Practice · PITTSFIELD, IL · NPI 1255331229

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	315	95
Lisinopril	Lisinopril	271	82
Levothyroxine Sodium	Levothyroxine Sodium	251	57
Furosemide	Furosemide	234	66
Potassium Chloride	Potassium Chloride	224	67
Eliquis	Apixaban	197	33
Amlodipine Besylate	Amlodipine Besylate	187	60
Metoprolol Succinate	Metoprolol Succinate	184	53
Omeprazole	Omeprazole	178	50
Metformin Hcl	Metformin Hcl	158	40
Gabapentin	Gabapentin	156	39
Pravastatin Sodium	Pravastatin Sodium	148	50
Losartan Potassium	Losartan Potassium	140	37
Metoprolol Tartrate	Metoprolol Tartrate	134	27
Sertraline Hcl	Sertraline Hcl	104	18
Ezetimibe	Ezetimibe	93	25
Citalopram Hbr	Citalopram Hydrobromide	86	27
Famotidine	Famotidine	84	22
Pantoprazole Sodium	Pantoprazole Sodium	84	27
Tramadol Hcl	Tramadol Hcl	81	31
Simvastatin	Simvastatin	77	27
Allopurinol	Allopurinol	74	20
Buspirone Hcl	Buspirone Hcl	71	18
Duloxetine Hcl	Duloxetine Hcl	71	18
Trazodone Hcl	Trazodone Hcl	71	17
Lovastatin	Lovastatin	68	11
Fluoxetine Hcl	Fluoxetine Hcl	65	15
Montelukast Sodium	Montelukast Sodium	62	14
Albuterol Sulfate Hfa	Albuterol Sulfate	58	23
Spironolactone	Spironolactone	58	21
Glipizide	Glipizide	56	19
Escitalopram Oxalate	Escitalopram Oxalate	55	suppressed
Clopidogrel	Clopidogrel Bisulfate	50	14
Fluticasone Propionate	Fluticasone Propionate	50	23
Tamsulosin Hcl	Tamsulosin Hcl	49	17
Glipizide Er	Glipizide	48	suppressed
Alendronate Sodium	Alendronate Sodium	46	15
Carbidopa-Levodopa	Carbidopa/Levodopa	46	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	46	suppressed
Lorazepam	Lorazepam	46	17
Hydrochlorothiazide	Hydrochlorothiazide	45	21
Donepezil Hcl	Donepezil Hcl	44	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	44	16
Xarelto	Rivaroxaban	43	suppressed
Atenolol	Atenolol	41	suppressed
Warfarin Sodium	Warfarin Sodium	40	suppressed
Diclofenac Sodium	Diclofenac Sodium	38	suppressed
Belsomra	Suvorexant	36	suppressed
Tizanidine Hcl	Tizanidine Hcl	36	11
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	35	suppressed
Mirtazapine	Mirtazapine	35	11
Meloxicam	Meloxicam	34	13
Nystatin	Nystatin	34	20
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	32	11
Latanoprost	Latanoprost	32	suppressed
Digoxin	Digoxin	30	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	30	suppressed
Carvedilol	Carvedilol	29	11
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	28	suppressed
Memantine Hcl	Memantine Hcl	28	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	28	suppressed
Fenofibrate	Fenofibrate	27	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	27	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	27	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	25	suppressed
Hydralazine Hcl	Hydralazine Hcl	25	suppressed
Glimepiride	Glimepiride	24	suppressed
Celecoxib	Celecoxib	23	suppressed
Metformin Hcl Er	Metformin Hcl	23	suppressed
Topiramate	Topiramate	23	suppressed
Baclofen	Baclofen	21	suppressed
Divalproex Sodium	Divalproex Sodium	21	suppressed
Insulin Aspart Flexpen	Insulin Aspart	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Finasteride	Finasteride	20	suppressed
Olanzapine	Olanzapine	20	suppressed
Ropinirole Hcl	Ropinirole Hcl	20	suppressed
Verapamil Er	Verapamil Hcl	20	suppressed
Ipratropium Bromide	Ipratropium Bromide	19	suppressed
Januvia	Sitagliptin Phosphate	19	suppressed
Tolterodine Tartrate	Tolterodine Tartrate	19	suppressed
Cephalexin	Cephalexin	18	13
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	18	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	18	suppressed
Lansoprazole	Lansoprazole	18	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	17	suppressed
Prednisone	Prednisone	17	suppressed
Alprazolam	Alprazolam	16	suppressed
Anastrozole	Anastrozole	16	suppressed
Azithromycin	Azithromycin	16	13
Nitroglycerin	Nitroglycerin	16	14
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	16	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Lurasidone Hcl	Lurasidone Hcl	15	suppressed
Myrbetriq	Mirabegron	15	suppressed
Nifedipine Er	Nifedipine	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Methotrexate	Methotrexate Sodium	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Pregabalin	Pregabalin	14	suppressed
Temazepam	Temazepam	14	suppressed
Jardiance	Empagliflozin	13	suppressed
Novolog Flexpen	Insulin Aspart	13	suppressed
Torsemide	Torsemide	13	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	12	12
Benazepril Hcl	Benazepril Hcl	12	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	12	suppressed
Nuedexta	Dextromethorphan Hbr/Quinidine	12	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	11	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error